| Dr Andrea Mignatti, MD | |
|
300 Community Drive, Cardiology Dept, Manhasset, NY 11030 | |
| (516) 562-0100 | |
| Not Available |
| Full Name | Dr Andrea Mignatti |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 18 Years |
| Location | 300 Community Drive, Manhasset, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245464577 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montefiore Medical Center | Bronx, NY | Hospital |
| Nyack Hospital | Nyack, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montefiore Medical Center | 3779496021 | 2003 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced financial results and highlights for the second quarter of 2014.
Women who abruptly and prematurely lose estrogen from surgical menopause have a two-fold increase in cognitive decline and dementia.
Responding to the Government's announcement of a 3.4 per cent increase in dental fees paid to dentists for NHS work, the British Dental Association warned that the measure would do nothing to improve access to NHS dentistry.
› Verified 4 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced financial results and highlights for the second quarter of 2014.
Women who abruptly and prematurely lose estrogen from surgical menopause have a two-fold increase in cognitive decline and dementia.
Responding to the Government's announcement of a 3.4 per cent increase in dental fees paid to dentists for NHS work, the British Dental Association warned that the measure would do nothing to improve access to NHS dentistry.
› Verified 4 days ago
| Entity Name | Wyckoff Professional Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659710796 PECOS PAC ID: 6406748607 Enrollment ID: O20040324001805 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced financial results and highlights for the second quarter of 2014.
Women who abruptly and prematurely lose estrogen from surgical menopause have a two-fold increase in cognitive decline and dementia.
Responding to the Government's announcement of a 3.4 per cent increase in dental fees paid to dentists for NHS work, the British Dental Association warned that the measure would do nothing to improve access to NHS dentistry.
› Verified 4 days ago
| Entity Name | Nassau Health Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902822992 PECOS PAC ID: 2961315221 Enrollment ID: O20040619000043 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced financial results and highlights for the second quarter of 2014.
Women who abruptly and prematurely lose estrogen from surgical menopause have a two-fold increase in cognitive decline and dementia.
Responding to the Government's announcement of a 3.4 per cent increase in dental fees paid to dentists for NHS work, the British Dental Association warned that the measure would do nothing to improve access to NHS dentistry.
› Verified 4 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced financial results and highlights for the second quarter of 2014.
Women who abruptly and prematurely lose estrogen from surgical menopause have a two-fold increase in cognitive decline and dementia.
Responding to the Government's announcement of a 3.4 per cent increase in dental fees paid to dentists for NHS work, the British Dental Association warned that the measure would do nothing to improve access to NHS dentistry.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrea Mignatti, MD 300 Community Drive, Cardiology Dept, Manhasset, NY 11030 Ph: (516) 562-4100 | Dr Andrea Mignatti, MD 300 Community Drive, Cardiology Dept, Manhasset, NY 11030 Ph: (516) 562-0100 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced financial results and highlights for the second quarter of 2014.
Women who abruptly and prematurely lose estrogen from surgical menopause have a two-fold increase in cognitive decline and dementia.
Responding to the Government's announcement of a 3.4 per cent increase in dental fees paid to dentists for NHS work, the British Dental Association warned that the measure would do nothing to improve access to NHS dentistry.
› Verified 4 days ago
Samit Shah, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 516-562-1427 | |
William J Berger, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 Northern Blvd Ste 201, Manhasset, NY 11030 Phone: 516-488-4428 Fax: 516-328-2723 | |
Lawrence Ong, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Nsuh Dept Of Medicine Cardiology, 300 Community Drive, Manhasset, NY 11030 Phone: 516-562-4103 | |
Dr. Malcolm E Levine, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 Northern Blvd, Manhasset, NY 11030 Phone: 516-627-1221 Fax: 516-627-6857 | |
Dr. Angela C Kim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 516-562-4280 Fax: 516-975-4994 | |
Dr. Roseann M Russo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1165 Northern Blvd, Suite 300, Manhasset, NY 11030 Phone: 516-608-6820 Fax: 516-608-6821 | |
Dr. Zahava Farkas, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 Community Dr Ste 302, Manhasset, NY 11030 Phone: 516-387-6826 |